Form 4: LifeStance Health Group Executive Ann Varanakis Reports Stock Transactions

Ann Varanakis, Chief People Officer of LifeStance Health Group, reports acquisition and disposal of company stock to cover tax obligations related to vesting of restricted stock units.

Summary

• On March 8, 2024, Ann Varanakis acquired 83,217 restricted stock units (RSUs) and 32,052 performance-based restricted stock units that vested.
• On March 11, 2024, Varanakis sold 15,434 shares of common stock at a price of $6.93 per share.
• The sale was to cover tax withholding obligations related to the vesting of the RSUs and was not a discretionary trade.
• Following these transactions, Varanakis beneficially owns 268,276 shares of LifeStance Health Group common stock.
• The transactions were reported on a Form 4 filing with the SEC.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, as it's a routine disclosure.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are often related to compensation packages and tax obligations. These transactions are closely monitored by investors for insights into management's perspective on the company's performance and future prospects.

Stakeholder Impact

• The transaction has a minimal impact on stakeholders as it is a routine sale of shares to cover tax obligations.

Key Dates